Development of a cross-sectoral antimicrobial resistance capability assessment framework
Antimicrobial resistance (AMR) is an urgent and growing global health concern, and a clear understanding of existing capacities to address AMR, particularly in low-income and middle-income countries (LMICs), is needed to inform national priorities, investment targets and development activities. Acro...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-01-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/9/1/e013280.full |
| _version_ | 1797334874150928384 |
|---|---|
| author | Andrew Stewardson Benjamin P Howden Kirsty Buising Trisha Peel Adam Jenney James Gilkerson Rodney James Angeline S Ferdinand Callum McEwan Chantel Lin Kassandra Betham Karishma Kandan Gilam Tamolsaian Barry Pugeva Joanna McKenzie Glenn Browning Mauricio Coppo Steph Levy Nicola Townell Donna Cameron Alison Macintyre |
| author_facet | Andrew Stewardson Benjamin P Howden Kirsty Buising Trisha Peel Adam Jenney James Gilkerson Rodney James Angeline S Ferdinand Callum McEwan Chantel Lin Kassandra Betham Karishma Kandan Gilam Tamolsaian Barry Pugeva Joanna McKenzie Glenn Browning Mauricio Coppo Steph Levy Nicola Townell Donna Cameron Alison Macintyre |
| author_sort | Andrew Stewardson |
| collection | DOAJ |
| description | Antimicrobial resistance (AMR) is an urgent and growing global health concern, and a clear understanding of existing capacities to address AMR, particularly in low-income and middle-income countries (LMICs), is needed to inform national priorities, investment targets and development activities. Across LMICs, there are limited data regarding existing mechanisms to address AMR, including national AMR policies, current infection prevention and antimicrobial prescribing practices, antimicrobial use in animals, and microbiological testing capacity for AMR. Despite the development of numerous individual tools designed to inform policy formulation and implementation or surveillance interventions to address AMR, there is an unmet need for easy-to-use instruments that together provide a detailed overview of AMR policy, practice and capacity. This paper describes the development of a framework comprising five assessment tools which provide a detailed assessment of country capacity to address AMR within both the human and animal health sectors. The framework is flexible to meet the needs of implementers, as tools can be used separately to assess the capacity of individual institutions or as a whole to align priority-setting and capacity-building with AMR National Action Plans (NAPs) or national policies. Development of the tools was conducted by a multidisciplinary team across three phases: (1) review of existing tools; (2) adaptation of existing tools; and (3) piloting, refinement and finalisation. The framework may be best used by projects which aim to build capacity and foster cross-sectoral collaborations towards the surveillance of AMR, and by LMICs wishing to conduct their own assessments to better understand capacity and capabilities to inform future investments or the implementation of NAPs for AMR. |
| first_indexed | 2024-03-08T08:28:34Z |
| format | Article |
| id | doaj.art-95108e1707c74a2d895df1b4145a0575 |
| institution | Directory Open Access Journal |
| issn | 2059-7908 |
| language | English |
| last_indexed | 2024-03-08T08:28:34Z |
| publishDate | 2024-01-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Global Health |
| spelling | doaj.art-95108e1707c74a2d895df1b4145a05752024-02-02T04:15:10ZengBMJ Publishing GroupBMJ Global Health2059-79082024-01-019110.1136/bmjgh-2023-013280Development of a cross-sectoral antimicrobial resistance capability assessment frameworkAndrew Stewardson0Benjamin P Howden1Kirsty Buising2Trisha Peel3Adam Jenney4James Gilkerson5Rodney James6Angeline S Ferdinand7Callum McEwan8Chantel Lin9Kassandra Betham10Karishma Kandan11Gilam Tamolsaian12Barry Pugeva13Joanna McKenzie14Glenn Browning15Mauricio Coppo16Steph Levy17Nicola Townell18Donna Cameron19Alison Macintyre20Department of Infectious Diseases, Alfred Health, Melbourne, Victoria, AustraliaWHO Collaborating Centre for Antimicrobial Resistance, Doherty Institute, Melbourne, Victoria, AustraliaWHO Collaborating Centre for Antimicrobial Resistance, Doherty Institute, Melbourne, Victoria, AustraliaDepartment of Infectious Diseases, Monash University and Alfred Health, Melbourne, Victoria, AustraliaDepartment of Infectious Diseases, Monash University, Clayton, Victoria, AustraliaAsia-Pacific Centre for Animal Health, Melbourne Veterinary School, The University of Melbourne, Melbourne, Victoria, AustraliaDoherty Institute, Melbourne, Victoria, AustraliaWHO Collaborating Centre for Antimicrobial Resistance, Doherty Institute, Melbourne, Victoria, AustraliaWHO Collaborating Centre for Antimicrobial Resistance, Doherty Institute, Melbourne, Victoria, AustraliaMicrobiological Diagnostic Unit Public Health Laboratory, The Peter Doherty Institute for Infection and Immunity at the University of Melbourne, Melbourne, Victoria, AustraliaWHO Collaborating Centre for Antimicrobial Resistance, Doherty Institute, Melbourne, Victoria, AustraliaWHO Collaborating Centre for Antimicrobial Resistance, Doherty Institute, Melbourne, Victoria, AustraliaBurnet Institute, Melbourne, Victoria, AustraliaBurnet Institute, Melbourne, Victoria, AustraliaMolecular Epidemiology Laboratory, School of Veterinary Science, Massey University, Palmerston North, New ZealandAsia-Pacific Centre for Animal Health, Melbourne Veterinary School, The University of Melbourne, Melbourne, Victoria, AustraliaAsia-Pacific Centre for Animal Health, Melbourne Veterinary School, The University of Melbourne, Melbourne, Victoria, AustraliaBurnet Institute, Melbourne, Victoria, AustraliaInfectious Disease Department, Sunshine Coast University Hospital, Sunshine Coast, Queensland, AustraliaWHO Collaborating Centre for Antimicrobial Resistance, Doherty Institute, Melbourne, Victoria, AustraliaNossal Institute for Global Health, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, AustraliaAntimicrobial resistance (AMR) is an urgent and growing global health concern, and a clear understanding of existing capacities to address AMR, particularly in low-income and middle-income countries (LMICs), is needed to inform national priorities, investment targets and development activities. Across LMICs, there are limited data regarding existing mechanisms to address AMR, including national AMR policies, current infection prevention and antimicrobial prescribing practices, antimicrobial use in animals, and microbiological testing capacity for AMR. Despite the development of numerous individual tools designed to inform policy formulation and implementation or surveillance interventions to address AMR, there is an unmet need for easy-to-use instruments that together provide a detailed overview of AMR policy, practice and capacity. This paper describes the development of a framework comprising five assessment tools which provide a detailed assessment of country capacity to address AMR within both the human and animal health sectors. The framework is flexible to meet the needs of implementers, as tools can be used separately to assess the capacity of individual institutions or as a whole to align priority-setting and capacity-building with AMR National Action Plans (NAPs) or national policies. Development of the tools was conducted by a multidisciplinary team across three phases: (1) review of existing tools; (2) adaptation of existing tools; and (3) piloting, refinement and finalisation. The framework may be best used by projects which aim to build capacity and foster cross-sectoral collaborations towards the surveillance of AMR, and by LMICs wishing to conduct their own assessments to better understand capacity and capabilities to inform future investments or the implementation of NAPs for AMR.https://gh.bmj.com/content/9/1/e013280.full |
| spellingShingle | Andrew Stewardson Benjamin P Howden Kirsty Buising Trisha Peel Adam Jenney James Gilkerson Rodney James Angeline S Ferdinand Callum McEwan Chantel Lin Kassandra Betham Karishma Kandan Gilam Tamolsaian Barry Pugeva Joanna McKenzie Glenn Browning Mauricio Coppo Steph Levy Nicola Townell Donna Cameron Alison Macintyre Development of a cross-sectoral antimicrobial resistance capability assessment framework BMJ Global Health |
| title | Development of a cross-sectoral antimicrobial resistance capability assessment framework |
| title_full | Development of a cross-sectoral antimicrobial resistance capability assessment framework |
| title_fullStr | Development of a cross-sectoral antimicrobial resistance capability assessment framework |
| title_full_unstemmed | Development of a cross-sectoral antimicrobial resistance capability assessment framework |
| title_short | Development of a cross-sectoral antimicrobial resistance capability assessment framework |
| title_sort | development of a cross sectoral antimicrobial resistance capability assessment framework |
| url | https://gh.bmj.com/content/9/1/e013280.full |
| work_keys_str_mv | AT andrewstewardson developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT benjaminphowden developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT kirstybuising developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT trishapeel developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT adamjenney developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT jamesgilkerson developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT rodneyjames developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT angelinesferdinand developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT callummcewan developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT chantellin developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT kassandrabetham developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT karishmakandan developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT gilamtamolsaian developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT barrypugeva developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT joannamckenzie developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT glennbrowning developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT mauriciocoppo developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT stephlevy developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT nicolatownell developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT donnacameron developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework AT alisonmacintyre developmentofacrosssectoralantimicrobialresistancecapabilityassessmentframework |